用户28964502982022-07-08 16:40
$美鼎生物(VIVO)$ $美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-189072查看全文
牛唐2022-07-08 15:08
韩国SD Biosensor和SJL Partners (Consortium)以15.3亿美元全现金收购$美鼎生物(VIVO)$ 。
$东方生物(SH688298)$ $金域医学(SH603882)$查看全文
$美鼎生物(VIVO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-20-329291 Act: 34 Size: 39 KB 网页链接
$美鼎生物(VIVO)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-003653 Act: 33 Size: 1 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-20-032096 Size: 5 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-20-032093 Size: 4 KB 网页链接
$美鼎生物(VIVO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-20-318636 Act: 34 Size: 799 KB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-20-030093 Size: 4 KB 网页链接
$美鼎生物(VIVO)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001193125-20-300880 Act: 33 Size: 788 KB 网页链接
$美鼎生物(VIVO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001193125-20-300813 Act: 34 Size: 13 MB 网页链接
$美鼎生物(VIVO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001127602-20-029387 Size: 6 KB 网页链接
$美鼎生物(VIVO)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001193125-20-292348 Act: 34 Size: 2 MB 网页链接